Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Hironic Co., Ltd. (149980:KRX), powered by AI.
Hironic Co., Ltd. is currently trading at ₩7,300. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Hironic Co., Ltd. on Alpha Lenz.
Hironic Co., Ltd.'s P/E ratio is -22.3.
“Hironic Co., Ltd. trades at a P/E of -22.3 (undervalued) with modest ROE of -7.7%. 3Y revenue CAGR of 13.2% highlights clear growth momentum.”
Ask for details →Hironic Co., Ltd. is a prominent player in the medical device industry, primarily focusing on the development and manufacture of innovative aesthetic and medical treatment equipment. The company specializes in technologies related to skin rejuvenation, body contouring, and laser-based devices, catering to both professional clinics and consumer markets. Its product lineup includes high-intensity focused ultrasound (HIFU) systems and radiofrequency devices, which are widely used in non-invasive cosmetic procedures to enhance skin appearance and reduce wrinkles without the need for surgery. As a significant contributor to the aesthetic medical device market, Hironic Co., Ltd. is at the forefront of integrating advanced technology and clinical research to improve the safety and efficacy of its products. The company's innovative solutions have made substantial impacts in dermatology and cosmetic medicine, playing a vital role in expanding accessible self-care options for beauty and healthcare professionals globally. Based in South Korea, Hironic Co., Ltd. taps into both the domestic and international markets, reflecting the increasing global demand for minimally invasive cosmetic interventions.
“Hironic Co., Ltd. trades at a P/E of -22.3 (undervalued) with modest ROE of -7.7%. 3Y revenue CAGR of 13.2% highlights clear growth momentum.”
Ask for details →Hironic Co., Ltd. (ticker: 149980) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 117 employees. Market cap is $154.7B.
The current price is ₩7,300 with a P/E ratio of -22.35x and P/B of 1.75x.
ROE is -7.68% and operating margin is -15.04%. Annual revenue is $31.6B.